Inventor
JI JIANGUO
US44 patents
⚠️ This page may combine multiple inventors who share the name “JI JIANGUO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
21 patentsUS7160876B2Jan 9, 2007
Fused bicycloheterocycle substituted quinuclidine derivatives
ABBOTT LAB46 citations96
US6809105B2Oct 26, 2004
Diazabicyclic central nervous system active agents
ABBOTT LAB53 citations95
US7674794B2Mar 9, 2010
Fused bicycloheterocycle substituted quinuclidine derivatives
ABBOTT LAB30 citations93
US7902222B2Mar 8, 2011
Biaryl substituted azabicyclic alkane derivatives
ABBOTT LAB28 citations92
US7872017B2Jan 18, 2011
Fused bicycloheterocycle substituted azabicyclic alkane derivatives
ABBOTT LAB31 citations92
US7399765B2Jul 15, 2008
Substituted diazabicycloalkane derivatives
ABBOTT LAB33 citations92
US6833370B1Dec 21, 2004
Heterocycle substituted aminoazacycles useful as central nervous system agents
ABBOTT LAB40 citations91
US6329536B1Dec 11, 2001
Stereoselective process for producing nitro compounds
ABBOTT LAB20 citations91
US7655657B2Feb 2, 2010
Fused bicycloheterocycle substituted quinuclidine derivatives
ABBOTT LAB44 citations88
US7309699B2Dec 18, 2007
3-Quinuclidinyl amino-substituted biaryl derivatives
ABBOTT LAB19 citations84
US7319106B2Jan 15, 2008
Diazabicyclic central nervous system active agents
ABBOTT LAB5 citations73
US7354937B2Apr 8, 2008
(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
ABBOTT LAB6 citations71
US7241773B2Jul 10, 2007
3-quinuclidinyl heteroatom bridged biaryl derivatives
ABBOTT LAB3 citations63
US7365193B2Apr 29, 2008
Amino-substituted tricyclic derivatives and methods of use
ABBOTT LAB3 citations62
US7332504B2Feb 19, 2008
Heterocyclic substituted aminoazacycles useful as central nervous system agents
ABBOTT LAB2 citations61
US7538226B2May 26, 2009
(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
ABBOTT LAB4 citations59
US8383658B2Feb 26, 2013
Isoxazole based neuronal nicotinic receptor ligands and methods of use
ABBOTT LAB0 citations52
US7872010B2Jan 18, 2011
Substituted diazabicycloalkane derivatives having affinity for nicotinic acetylcholine receptors
ABBOTT LAB0 citations52
US7598236B2Oct 6, 2009
Diazabicyclic central nervous system active agents
ABBOTT LAB0 citations52
US7951791B2May 31, 2011
Amino-substituted tricyclic derivatives and methods of use
ABBOTT LAB0 citations51
US7045530B2May 16, 2006
Spirocyclic quinuclidinic ether derivatives
ABBOTT LAB0 citations42
ABBVIE SARL
4 patentsUS10259810B2Apr 16, 2019
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL5 citations82
US9890158B2Feb 13, 2018
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL5 citations81
US10647717B2May 12, 2020
N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL1 citations71
US10130622B2Nov 20, 2018
Compounds for treatment of cystic fibrosis
ABBVIE SARL0 citations37
SCHRIMPF MICHAEL R
3 patentsUS8314119B2Nov 20, 2012
Azaadamantane derivatives and methods of use
SCHRIMPF MICHAEL R22 citations92
US8163916B2Apr 24, 2012
Azaadamantane ester and carbamate derivatives and methods of use thereof
SCHRIMPF MICHAEL R5 citations62
US8119635B2Feb 21, 2012
Diazabicyclic central nervous system active agents
SCHRIMPF MICHAEL R2 citations62
JI JIANGUO
3 patentsHUTCHISON MEDIPHARMA LTD
3 patentsUS10052330B2Aug 21, 2018
Substituted pyrido[3,4-b]pyrazines as Syk inhibitors
HUTCHISON MEDIPHARMA LTD2 citations73
US10369153B2Aug 6, 2019
Pyrrolopyrimidine compounds and uses thereof
HUTCHISON MEDIPHARMA LTD0 citations51
US10111875B2Oct 30, 2018
Pyrrolopyrimidine compounds and uses thereof
HUTCHISON MEDIPHARMA LTD1 citations51